None listed
Conditions
Brief summary
This study will determine whether a cognitive rehabilitation intervention, ReCog, has an effect on cognitive function in cancer survivors. Who is it for? You may be eligible to join this study if you are aged 18 years or above, have had a previous diagnosis of breast cancer, had chemotherapy treatment at Mater Cancer Care Centre, Brisbane, and completed all major cancer treatments. Study details All participants in this study will receive a group education and skills training intervention called “Responding to Cognitive Concerns” (ReCog). The program is based on self-regulatory cognitive rehabilitation and cognitive behavioural principles, and employs manuals for clinicians and participants. The program is run in small groups of approximately 4-9 participants. There will be four sessions run at weekly intervals by an occupational therapist and each session will last for 2 hours. Patients will be asked to practise the learnt strategies and skills in and between sessions, with the ultimate goal of generalising these strategies to their everyday life. Home tasks are expected to take approximately 15 minutes per day. Participants' performance on cognitive tasks (such as tests of memory and attention) will occur before and after the group program. Questionnaires on psychological distress, quality of life, psychological needs and satisfaction will be administered after the group program. It is hypothesised that both their cognitive performance on standard tests and reported everyday cognitive performance on questionnaires will improve.
Interventions
The program to be evaluated is a group education and skills training intervention, called “Responding to Cognitive Concerns” (ReCog), which has previously successfully improved subjective and objective cognitive function in survivors of breast cancer and other types of cancer. The program is based on self -regulatory cognitive rehabilitation and cognitive behavioural principles, and employs manuals for clinicians and participants. The program is run in small groups of approximately 4-9 participa
The program to be evaluated is a group education and skills training intervention, called “Responding to Cognitive Concerns” (ReCog), which has previously successfully improved subjective and objective cognitive function in survivors of breast cancer and other types of cancer. The program is based on self -regulatory cognitive rehabilitation and cognitive behavioural principles, and employs manuals for clinicians and participants. The program is run in small groups of approximately 4-9 participants. There will be four sessions run at weekly intervals by an occupational therapist, with assistance from an occupational therapy assistant and occupational therapy student, and each session will last for 2 hours. Patients will be asked to practise the learnt strategies and skills in and between sessions, with the ultimate goal of generalising these strategies to their everyday life. Home tasks are expected to take approximately 15 minutes per day. Adherence to the intervention will be monitored via attendance at sessions and completion of home tasks.
Sponsors
Dr Heather Green
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants will meet the following inclusion criteria: (a) Previous diagnosis of breast cancer; (b) age 18 years or more; (c) previous treatment with chemotherapy for breast cancer at the Mater Cancer Care Centre, Brisbane; (d) completion of all major cancer treatments (such as surgery, chemotherapy, and radiotherapy) 6 to 60 months before participating in the research; (e) no current or anticipated cancer treatments apart from hormonal medications, if prescribed; (f) self-reported cognitive complaints; and (g) ability to speak, read, and write English fluently.
Exclusion criteria
The following exclusion criteria will be used: (a) Childhood cancer history; (b) known primary or secondary tumour involving the central nervous system; (c) history of intracranial radiotherapy or intrathecal chemotherapy
Outcome results
None listed